Yoshimi A - Search Results

1

Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.

Yoshimi A, Goyama S, Watanabe-Okochi N, Yoshiki Y, Nannya Y, Nitta E, Arai S, Sato T, Shimabe M, Nakagawa M, Imai Y, Kitamura T, Kurokawa M. Yoshimi A, et al. Blood. 2011 Mar 31;117(13):3617-28. doi: 10.1182/blood-2009-12-261602. Epub 2011 Feb 2. Blood. 2011. PMID: 21289308 Free article.

2

[Effective treatment with rituximab in two patients with Waldenström macroglobulinemia].

Yoshimi A, Arai S, Iijima K, Iki S, Usuki K, Urabe A. Yoshimi A, et al. Rinsho Ketsueki. 2005 Oct;46(10):1109-13. Rinsho Ketsueki. 2005. PMID: 16440772 Japanese.

3

Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation.

Yoshimi A, Izutsu K, Takahashi M, Kako S, Oshima K, Kanda Y, Motokura T, Chiba S, Momose T, Ohtomo K, Kurokawa M. Yoshimi A, et al. Am J Hematol. 2008 Jun;83(6):477-81. doi: 10.1002/ajh.21158. Am J Hematol. 2008. PMID: 18266206 Free article.

4

ESHAP therapy effective in a patient with Langerhans cell sarcoma.

Yoshimi A, Kumano K, Motokura T, Takazawa Y, Oota S, Chiba S, Takahashi T, Fukayama M, Kurokawa M. Yoshimi A, et al. Int J Hematol. 2008 Jun;87(5):532-537. doi: 10.1007/s12185-008-0075-6. Epub 2008 Apr 17. Int J Hematol. 2008. PMID: 18415657

5

A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation.

Yoshimi A, Nannya Y, Sakata-Yanagimoto M, Oshima K, Takahashi T, Kanda Y, Motokura T, Chiba S, Kurokawa M. Yoshimi A, et al. Am J Hematol. 2008 Aug;83(8):635-9. doi: 10.1002/ajh.21208. Am J Hematol. 2008. PMID: 18506704 Free article.

6

Successful hematopoietic stem cell transplantation from an HLA-identical sibling in a patient with aplastic anemia after HLA-haploidentical living-related liver transplantation for fulminant hepatitis.

Yoshimi A, Nannya Y, Ueda K, Asano D, Yamamoto G, Kumano K, Hangaishi A, Matsui Y, Takahashi T, Imai Y, Sugawara Y, Kokudo N, Kurokawa M. Yoshimi A, et al. Biol Blood Marrow Transplant. 2009 Mar;15(3):389-90. doi: 10.1016/j.bbmt.2008.11.021. Biol Blood Marrow Transplant. 2009. PMID: 19203732 Free article. No abstract available.

7

Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.

Shimabe M, Goyama S, Watanabe-Okochi N, Yoshimi A, Ichikawa M, Imai Y, Kurokawa M. Shimabe M, et al. Among authors: yoshimi a. Oncogene. 2009 Dec 10;28(49):4364-74. doi: 10.1038/onc.2009.288. Oncogene. 2009. PMID: 19767769

8

Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.

Arai S, Yoshimi A, Shimabe M, Ichikawa M, Nakagawa M, Imai Y, Goyama S, Kurokawa M. Arai S, et al. Among authors: yoshimi a. Blood. 2011 Jun 9;117(23):6304-14. doi: 10.1182/blood-2009-07-234310. Epub 2010 Dec 29. Blood. 2011. PMID: 21190993 Free article.

9

Key roles of histone methyltransferase and demethylase in leukemogenesis.

Yoshimi A, Kurokawa M. Yoshimi A, et al. J Cell Biochem. 2011 Feb;112(2):415-24. doi: 10.1002/jcb.22972. J Cell Biochem. 2011. PMID: 21268062 Review.

10

Evi1 forms a bridge between the epigenetic machinery and signaling pathways.

Yoshimi A, Kurokawa M. Yoshimi A, et al. Oncotarget. 2011 Jul;2(7):575-86. doi: 10.18632/oncotarget.304. Oncotarget. 2011. PMID: 21795762 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters